adoptive T-cell therapy (Immunicum)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameadoptive T-cell therapy (Immunicum)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMendus AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMendus AB
Active IndicationsN/A
Inactive IndicationsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A